\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ underwent\\ successful\\ resection\\.\ \(0\)\
\-\ axial\\ ct\\ with\\ contrast\\ reveals\\ a\\ spiculated\\ non\\-enhancing\\ nodular\\ lesion\\ within\\ the\\ right\\ lower\\ lobe\\ with\\ areas\\ of\\ internal\\ hypodensity\\.\ \(0\)\
\-\ pet\\ \\(not\\ included\\)\\ evaluation\\ revealed\\ significant\\ suv\\ within\\ the\\ lesion\\.\ \(0\)\
\-\ large\\ cell\\ carcinoma\ \(1\)\
\-\ carcinoma\ \(1182\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ noncalcified\\ granuloma\ \(0\)\
\-\ hamartoma\ \(55\)\
\-\ avm\ \(1\)\
\-\ 79\\ year\\ old\\ female\\ with\\ incidental\\ findings\\ of\\ a\\ right\\ lung\\ nodule\\ on\\ virtual\\ colonography\\.\ \(1\)\
\-\ this\\ is\\ an\\ uncomplicated\\ presentation\\ of\\ a\\ common\\ malignancy\\.\\ \\ undoubtedly\\,\\ the\\ patient\\'s\\ disease\\ would\\ have\\ progressed\\ significantly\\ had\\ she\\ not\\ sought\\ screening\\ ct\\ colonography\\.\\ \\ one\\ of\\ the\\ benefits\\ of\\ screening\\ ct\\ colonography\\ is\\ in\\ finding\\ extra\\-colonic\\ disease\\.\\ \\ clinically\\ significant\\ findings\\ depend\\ upon\\ the\\ screened\\ population\\ where\\ age\\ is\\ the\\ most\\ important\\ factor\\ determining\\ risk\\ for\\ extra\\-colonic\\ malignancy\\.\\ \\ it\\ is\\ generally\\ agreed\\ that\\ in\\ older\\ populations\\ \\(\\>70\\ y\\/o\\)\\,\\ the\\ ct\\ colonography\\ technique\\ has\\ benefit\\ in\\ findings\\ significant\\ extra\\-colonic\\ disease\\ whereas\\ virtual\\ colonography\\ and\\ the\\ potential\\ benefit\\ in\\ discovering\\ extra\\-colonic\\ findings\\ important\\ in\\ a\\ younger\\ screening\\ population\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ extra\\-colonic\\:\\ 0\\.20621095728576602\ \(0\)\
\-\ colonography\\:\\ 0\\.20537306885200124\ \(0\)\
\-\ virtual\\:\\ 0\\.0731060709532744\ \(0\)\
\-\ screening\\:\\ 0\\.0639479724373394\ \(0\)\
\-\ benefit\\:\\ 0\\.05967188721944082\ \(0\)\
\-\ population\\:\\ 0\\.05214981985119189\ \(0\)\
\-\ \\-pet\\:\\ 0\\.051552739321441506\ \(0\)\
\-\ \\-axial\\:\\ 0\\.04749924703746522\ \(0\)\
\-\ discovering\\:\\ 0\\.04749924703746522\ \(0\)\
\-\ important\\:\\ 0\\.04489806645082951\ \(0\)\
\-\ undoubtedly\\:\\ 0\\.04344575475348893\ \(0\)\
\-\ findings\\:\\ 0\\.042545893234852854\ \(0\)\
\-\ agreed\\:\\ 0\\.041074613770400246\ \(0\)\
\-\ significant\\:\\ 0\\.040313107913231984\ \(0\)\
\-\ noncalcified\\:\\ 0\\.03939226246951264\ \(0\)\
\-\ screened\\:\\ 0\\.03939226246951264\ \(0\)\
\-\ malignancy\\:\\ 0\\.0386209319041113\ \(0\)\
\-\ populations\\:\\ 0\\.03702112148642396\ \(0\)\
\-\ sought\\:\\ 0\\.03611965552252187\ \(0\)\
\-\ depend\\:\\ 0\\.03571618843780285\ \(0\)\
\-\ suv\\:\\ 0\\.03433379792280736\ \(0\)\
\-\ benefits\\:\\ 0\\.03296762920244767\ \(0\)\
\-\ determining\\:\\ 0\\.03296762920244767\ \(0\)\
\-\ disease\\:\\ 0\\.03267222318633226\ \(0\)\
\-\ 79\\:\\ 0\\.03186095084198844\ \(0\)\
\-\ hypodensity\\:\\ 0\\.03076123018992447\ \(0\)\
\-\ spiculated\\:\\ 0\\.030436260300130254\ \(0\)\
\-\ non\\-enhancing\\:\\ 0\\.030436260300130254\ \(0\)\
\-\ whereas\\:\\ 0\\.029695022255456897\ \(0\)\
\-\ younger\\:\\ 0\\.02916302355249943\ \(0\)\
\-\ progressed\\:\\ 0\\.02891413691847139\ \(0\)\
\-\ technique\\:\\ 0\\.028793556291554803\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02832663941539025\ \(0\)\
\-\ uncomplicated\\:\\ 0\\.028118042331777934\ \(0\)\
\-\ ct\\:\\ 0\\.027960319377591646\ \(0\)\
\-\ hamartoma\\:\\ 0\\.02732388127236822\ \(0\)\
\-\ successful\\:\\ 0\\.026624786824123874\ \(0\)\
\-\ significantly\\:\\ 0\\.025572322616819774\ \(0\)\
\-\ factor\\:\\ 0\\.025503924723467776\ \(0\)\
\-\ older\\:\\ 0\\.02517344396169385\ \(0\)\
\-\ granuloma\\:\\ 0\\.024563730451024786\ \(0\)\
\-\ potential\\:\\ 0\\.024064550047801645\ \(0\)\
\-\ 70\\:\\ 0\\.024011627033065287\ \(0\)\
\-\ avm\\:\\ 0\\.023804598219902034\ \(0\)\
\-\ included\\:\\ 0\\.023042813454768107\ \(0\)\
\-\ generally\\:\\ 0\\.022489503651406416\ \(0\)\
\-\ clinically\\:\\ 0\\.02191002468857466\ \(0\)\
\-\ nodular\\:\\ 0\\.020961460860303576\ \(0\)\
\-\ nodule\\:\\ 0\\.020597740346444477\ \(0\)\
\-\ upon\\:\\ 0\\.020424025993146723\ \(0\)\
\-\ where\\:\\ 0\\.02039556874372466\ \(0\)\
\-\ lesion\\:\\ 0\\.020357371064332802\ \(0\)\
\-\ reveals\\:\\ 0\\.019551156434473818\ \(0\)\
\-\ within\\:\\ 0\\.019065864425568204\ \(0\)\
\-\ incidental\\:\\ 0\\.01892274033906594\ \(0\)\
\-\ risk\\:\\ 0\\.018100623668766587\ \(0\)\
\-\ would\\:\\ 0\\.017783432037556078\ \(0\)\
\-\ presentation\\:\\ 0\\.017212869207550188\ \(0\)\
\-\ underwent\\:\\ 0\\.017147345236714732\ \(0\)\
\-\ areas\\:\\ 0\\.016814895738281092\ \(0\)\
\-\ internal\\:\\ 0\\.01675366006654252\ \(0\)\
\-\ \\>\\:\\ 0\\.01660331879923137\ \(0\)\
\-\ finding\\:\\ 0\\.016105622836482345\ \(0\)\
\-\ revealed\\:\\ 0\\.01603785900506487\ \(0\)\
\-\ resection\\:\\ 0\\.015584302079065606\ \(0\)\
\-\ age\\:\\ 0\\.015210001903767874\ \(0\)\
\-\ evaluation\\:\\ 0\\.014516016349864371\ \(0\)\
\-\ lung\\:\\ 0\\.014474614738238281\ \(0\)\
\-\ not\\:\\ 0\\.014442323646104507\ \(0\)\
\-\ she\\:\\ 0\\.014027989131310948\ \(0\)\
\-\ y\\/o\\:\\ 0\\.013839935846898483\ \(0\)\
\-\ one\\:\\ 0\\.013542288791290316\ \(0\)\
\-\ cell\\:\\ 0\\.013498483693458983\ \(0\)\
\-\ lobe\\:\\ 0\\.013446347063880315\ \(0\)\
\-\ is\\:\\ 0\\.01315300066397019\ \(0\)\
\-\ common\\:\\ 0\\.013077586034832731\ \(0\)\
\-\ metastatic\\:\\ 0\\.01257958715564965\ \(0\)\
\-\ in\\:\\ 0\\.012321556436849559\ \(0\)\
\-\ most\\:\\ 0\\.011537047612444888\ \(0\)\
\-\ lower\\:\\ 0\\.011238959469964109\ \(0\)\
\-\ it\\:\\ 0\\.011233031488497172\ \(0\)\
\-\ contrast\\:\\ 0\\.01118582272987079\ \(0\)\
\-\ \\'s\\:\\ 0\\.011017816481678626\ \(0\)\
\-\ large\\:\\ 0\\.010927148724158361\ \(0\)\
\-\ have\\:\\ 0\\.010821275312076559\ \(0\)\
\-\ had\\:\\ 0\\.010782747480939813\ \(0\)\
\-\ right\\:\\ 0\\.010545400106554581\ \(0\)\
\-\ female\\:\\ 0\\.010273451879811893\ \(0\)\
\-\ patient\\:\\ 0\\.010018619075045473\ \(0\)\
\-\ has\\:\\ 0\\.009384210353767707\ \(0\)\
\-\ a\\:\\ 0\\.009277188346633948\ \(0\)\
\-\ that\\:\\ 0\\.008631466248882008\ \(0\)\
\-\ \\(\\:\\ 0\\.008448675160746906\ \(0\)\
\-\ \\)\\:\\ 0\\.008345470083196551\ \(0\)\
\-\ an\\:\\ 0\\.00691032084377035\ \(0\)\
\-\ the\\:\\ 0\\.006467802793152084\ \(0\)\
\-\ this\\:\\ 0\\.005620685457977386\ \(0\)\
\-\ year\\:\\ 0\\.005591258884636928\ \(0\)\
\-\ old\\:\\ 0\\.005116576589837746\ \(0\)\
\-\ for\\:\\ 0\\.004263790342939854\ \(0\)\
\-\ on\\:\\ 0\\.0042332807740668305\ \(0\)\
\-\ of\\:\\ 0\\.0034065438829821177\ \(0\)\
\-\ \\,\\:\\ 0\\.0031661995966934193\ \(0\)\
\-\ with\\:\\ 0\\.0020527048436822758\ \(0\)\
\-\ \\.\\:\\ 0\\.0018683966367024354\ \(0\)\
\-\ and\\:\\ 0\\.001052684244048061\ \(0\)\
